Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NSUN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRKRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL17RB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DEPDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF1AX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R3E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GK5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF831 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AURKA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMPAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNJ2BP-COX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on